Since Parkinson’s is caused by a dopamine deficiency in the brain, what if we ate foods rich in the dopamine precursor levodopa?
Friday Favorites: Can Velvet Beans or Fava Beans Help Treat Parkinson’s Disease?
Below is an approximation of this video’s audio content. To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video.
Intro: Treating Parkinson’s disease with velvet beans. I have several videos on foods that may trigger Parkinson’s disease, but how can diet be used in treatment? This video and the next look at beans for treating this disease.
Two centuries have passed since James Parkinson’s Essay on the Shaking Palsy described a disease characterized by tremor and problems with movement. Today, treatment options include surgically implanting electrodes into the brain. There has to be a better way.
We’ve known since the 1950s that Parkinson’s disease is manifested by a dopamine deficiency in the brain. Well, then why not eat a dopamine diet? A variety of fruits and vegetables contain the same dopamine made by our brain. Unfortunately, dopamine can’t cross the blood-brain barrier, and hence is ineffective as therapy. However, the dopamine precursor, known as L-dopa or levodopa, can get from the blood up into the brain, where it can then be converted to dopamine within the brain by an enzyme called decarboxylase. We don’t want the levodopa to be converted to dopamine outside the brain, because then it can’t get in. So, we give people a decarboxylase inhibitor, which itself can’t get into the brain; so, that keeps levodopa from prematurely turning into dopamine before it gets into the brain where we need it.
So, eating dopamine-rich foods doesn’t help, but what if we ate levodopa-rich foods? More than 1,500 years before Dr. Parkinson came on the scene, an Indian physician seems to have nailed it, and even suggested a treatment—velvet beans, the plant with the highest amount of L-dopa. Hmm; so, might there be a way to forestall the epidemic of Parkinson’s disease through plant-based remedies after all?
Levodopa is the gold standard therapy for Parkinson’s patients, but most Parkinson’s patients in low-income areas cannot afford long-term daily levodopa therapy. In rural Africa, for example, it is estimated that only 15 percent of patients are treated with levodopa, because the daily cost of levodopa treatment is about a dollar a day, which may be half of what people make in a day. It’s the same with other regions of the Global South. L-dopa is mostly unavailable or unaffordable. So, patients frequently use powdered velvet beans as a replacement or supplement to the drug.
But does it work? You never know, until you put it to the test. Velvet beans in Parkinson’s disease: a randomized, double blind clinical study. And…a dose of 30g (which is about three tablespoons) led to reliable and sustained antiparkinsonian effects in all patients, working significantly quicker than the drug; working significantly longer than the drug; and working significantly better than the drug in another double-blind, randomized, head-to-head crossover study.
The levodopa in velvet beans appears to be two to three times more potent as compared to the same dose of pill-form levodopa––suspected to be because there may be some intrinsic decarboxylase inhibitor compound in the plant as well.
Okay, but those were single dose studies. What about the chronic use of velvet beans for Parkinson’s? Fourteen patients with advanced Parkinson’s received roasted velvet bean powder or the standard drug, switching back and forth for months, looking at changes in quality of life, activities of daily living, movement and non-movement symptoms, and time with good mobility without troublesome involuntary writhing movements. The velvet beans seemed to work as well as the drug in all measures of efficacy, including quality of life. Here’s a video you can see someone with Parkinson’s solely treated with velvet bean powder for 14 years, before and after treatment.
Despite the efficacy, the chances of this cheap herbal remedy ever being licensed seems unlikely—and for good reason. First of all, the stuff evidently tastes nasty. And we don’t really have good data going out more than a few months. While velvet beans may potentially be part of the answer to Parkinson’s disease management in low-income countries, in high-income countries, one may be tempted to prefer them to drugs just because it is a “more natural therapy,” but researchers discourage patients and physicians to consider its use when the drugs are available. So, levodopa in pill form should remain the first-line treatment for Parkinson’s. However, velvet bean powder may be better tolerated in certain patients. Psychologically, some patients just have a thing against taking pills and so, if they refuse, then certainly the beans can step in. But otherwise, velvet bean supplements suffer from the same issues common to all supplements, specifically lack of sufficient regulation and quality control. There are all sorts of brands out there, but there are no head-to-head comparisons as to which is best, and the quality of the products likely vary. But you don’t know, until you put it to the test.
Six brands of velvet bean products were ordered through the internet and most of them, four out of six, showed a large discrepancy between the claim on their label and the actual L-Dopa content, and only two even came close. The remaining products contained considerably less—less than 10 percent in two cases. Too bad there isn’t a food source of L-dopa that you could just eat instead of taking in a supplement. Well, wait a second. L-dopa was originally discovered more than a century ago in faba beans. Might eating faba beans help with Parkinson’s? I’ll explore just that question next.
“Increased risk of Parkinson’s disease has been associated with exposure to pesticides, consumption of dairy products, a history of melanoma, and traumatic brain injury.” Why is the risk of Parkinson’s disease increased among individuals with high milk and dairy consumption? It could be the animal fat, or maybe the animal protein. So, why not use a plant-food diet for the risk and management of Parkinson’s disease? There are phytochemicals that may target the underlying cause, but in terms of treatment, ancient sacred texts from thousands of years ago refer to “trembling” individuals who were prescribed a plant from the bean family to treat the condition.
In my last video, Treating Parkinson’s Disease with Velvet Beans, I talked about the use of velvet beans. But in 1913, the miracle drug L-dopa was discovered for the first time in faba beans, also known as fava beans or broad beans, as a natural source of L-dopa to consider. The amount varies considerably based on a number of factors, but typically it looks like they have about 10 times less than velvet beans. But that’s okay since you can eat larger quantities, since fava beans are an actual food instead of a powdered supplement. The important thing is that the amount of L-dopa in fava beans is enough to be pharmacologically active in Parkinson’s disease. In fact, there are some reports indicating that Parkinson’s patients might respond better to the beans than to standard L-dopa preparations in pill form. But anecdotal reports that patients may gain benefit from a broad bean-rich diet don’t cut it. What you have to do is put it to the test.
Parkinson’s patients were fed about one and a third cups of cooked fava beans, and during the next four hours, a substantial clinical improvement was noted. In fact, it was similar to the improvement seen after receiving the standard pharmacological combination of L-dopa plus carbidopa, the decarboxylase inhibitor drug I talked about in the last video that boosts L-dopa levels in the brain. It’s no surprise that there was a similar effect, since they had very similar L-dopa levels in the blood. In fact, half the time you could hardly tell the beans from the drugs. How could there be the same levels if the bean L-dopa lacked the carbidopa booster drug? Because fava beans may not only be a natural source of L-dopa, but a natural source of the carbidopa booster too. So, the consumption of fava beans has the potential to increase the levels of L-dopa and carbidopa in the blood, with a marked improvement in the muscle movement performance of the patients with Parkinson disease, without any side effects.
In fact, they work so well you have to be careful about abruptly stopping them. There’s a condition called neuroleptic malignant-like syndrome, characterized by fever, rigidity, all sorts of neurological problems, muscle breakdown, and altered levels of consciousness, which is usually precipitated by an abrupt withdrawal of the L-dopa drug, caused by an acute dopamine-deficient state. Well, you can see the same thing if you’re treating your Parkinson’s with fava beans, and then all the sudden you stop them. Ten days before hospital admission, this poor guy’s garden ran out of beans, leading to a severe crippling rigidity. This case demonstrates that alternative therapies carry similar risks to traditional agents, because in this case they really are the ultimate traditional agent.
There are some downsides you don’t see with the drug, though. Like fava-induced flatulence. You also have to be careful with fava consumption if you’re on MAO inhibitor drugs, often used as anti-depressants, since there can be drug interactions.
And then there is the risk of a condition known as favism. There is a genetic mutation that occurs in about 1 in 20 people, and at even higher rates in those of African and Mediterranean descent, in which people lack an enzyme that’s necessary to detoxify certain compounds found in fava beans. And without the enzyme, fava bean consumption can cause your red blood cells to rupture. Thankfully, genetic testing for this mutation is widely available and affordable, and so it would seem prudent to screen patients with Parkinson’s for this favism, called G6PD deficiency mutation, prior to putting them on daily fava bean consumption.
If you do want to give fava beans a try, fresh green fava beans have significantly more L-dopa than dried. So much so that dried fava beans may not provide any clinical benefits.
Roasting and boiling removes some or even all of the L-dopa, though other studies have found that about a half cup of cooked favas contain approximately 250 mg. Sprouted favas may have the most, increasing up until day nine, by which time the indigestible flatulence sugars may be eliminated, offering another advantage of fava bean sprouting. But you don’t know if fava bean sprouts help until you put them to the test.
Researchers fed Parkinson’s patients a salad with about a half cup of freshly chopped fava sprouts and observed substantial clinical improvement.
Other beans, just like regular beans, also naturally have L-dopa, though at lower amounts. Soybeans have a bonus compound that may act as an L-dopa-boosting carbidopa compound. What if you fed people soybeans on top of their regular Parkinson’s meds? Giving people just one and a half spoonful’s worth of roasted soybeans led to a significant improvement over the drugs alone, with significantly fewer involuntary movements hours later.
Until more information is available, Parkinson’s combo drugs like Sinemet should remain the first-line therapy, but adding beans to one’s diet may only help.
Please consider volunteering to help out on the site.
- Del Rey NL, Quiroga-Varela A, Garbayo E, et al. Advances in Parkinson's Disease: 200 Years Later. Front Neuroanat. 2018;12:113.
- Hornykiewicz O. The discovery of dopamine deficiency in the parkinsonian brain. J Neural Transm Suppl. 2006;(70):9-15.
- Briguglio M, Dell'Osso B, Panzica G, et al. Dietary Neurotransmitters: A Narrative Review on Current Knowledge. Nutrients. 2018;10(5):591.
- Ahlskog JE. Parkinson’s disease: medical and surgical treatment. Neurol Clin. 2001;19(3):579-605, vi.
- Rijntjes M. Knowing Your Beans in Parkinson's Disease: A Critical Assessment of Current Knowledge about Different Beans and Their Compounds in the Treatment of Parkinson's Disease and in Animal Models. Parkinsons Dis. 2019;2019:1349509.
- Banjari I, Marček T, Tomić S, Waisundara VY. Forestalling the Epidemics of Parkinson's Disease Through Plant-Based Remedies. Front Nutr. 2018;5:95.
- Cassani E, Cilia R, Laguna J, et al. Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile. J Neurol Sci. 2016;365:175-180.
- Cilia R, Laguna J, Cassani E, et al. Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study. Neurology. 2017;89(5):432-438.
- Merello M. The Dark Side of Globalization: Lack of Universal Levodopa Availability. Mov Disord Clin Pract. 2018;6(1):7-8.
- Katzenschlager R, Evans A, Manson A, et al. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004;75(12):1672-1677.
- Rai SN, Birla H, Zahra W, Singh SS, Singh SP. Immunomodulation of Parkinson's disease using Mucuna pruriens (Mp). J Chem Neuroanat. 2017;85:27-35.
- Cilia R, Laguna J, Cassani E, et al. Chronic Mucuna pruriens in Parkinson’s disease: a non-inferiority, randomised, crossover, phase-2b trial. Parkinsonism Relat Disord. 2018;46:e24.
- Lees AJ. Advice for those trying to find a cure for the shaking palsy. Lancet Neurol. 2018;17(1):27-28.
- Cilia R, Laguna J, Cassani E, et al. Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study. Parkinsonism Relat Disord. 2018;49:60-66.
- Fothergill-Misbah N, Maroo H, Cham M, Pezzoli G, Walker R, Cilia R. Could Mucuna pruriens be the answer to Parkinson's disease management in sub-Saharan Africa and other low-income countries worldwide?. Parkinsonism Relat Disord. 2020;73:3-7.
- Margolesky J, Shpiner DS, Moore H, Singer C, Jagid J, Luca CC. From Mucuna Pruriens to deep brain stimulation: A two-decade case history. Parkinsonism Relat Disord. 2020;77:26-27.
- Denne T. Analysis of Levodopa Content in Commercial Formulations of Mucuna pruriens Seeds Used in Integrative Treatment of Parkinson’s Disease [abstract]. Mov Disord. 2019; 34 (suppl 2).
- Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257-1272.
- Baroni L, Zuliani C. A plant-food diet in the risk and management of parkinson’s disease. In: Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. Elsevier; 2015:411-420.
- Javed H, Nagoor Meeran MF, Azimullah S, Adem A, Sadek B, Ojha SK. Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models. Front Pharmacol. 2019;9:1555.
- Ramírez-Moreno JM, Salguero Bodes I, Romaskevych O, Duran-Herrera MC. Broad bean (Vicia faba) consumption and Parkinson's disease: a natural source of L-dopa to consider. Neurologia. 2015;30(6):375-376.
- Cilia R, Laguna J, Cassani E, et al. Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study. Neurology. 2017;89(5):432-438.
- Guggenheim M. Dioxyphenylalanin, eine neue Aminosäure aus Vicia faba. Z Phys Chem. 1913;88:276.
- Rijntjes M. Knowing Your Beans in Parkinson's Disease: A Critical Assessment of Current Knowledge about Different Beans and Their Compounds in the Treatment of Parkinson's Disease and in Animal Models. Parkinsons Dis. 2019;2019:1349509.
- Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M. Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants. Curr Pharm Des. 2016;22(2):238-246.
- Kempster PA, Bogetic Z, Secombei JW, Martin HD, Balazs ND, Wahlqvist ML. Motor effects of broad beans (Vicia faba) in Parkinson's disease: single dose studies. Asia Pac J Clin Nutr. 1993;2(2):85-89.
- Rabey JM, Vered Y, Shabtai H, Graff E, Korczyn AD. Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption. J Neurol Neurosurg Psychiatry. 1992;55(8):725-727.
- Mehran S M M, B G. Simultaneous determination of levodopa and carbidopa from fava bean, green peas and green beans by high performance liquid gas chromatography. J Clin Diagn Res. 2013;7(6):1004-1007.
- Ladha SS, Walker R, Shill HA. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance. Mov Disord. 2005;20(5):630-631.
- Katzenschlager R, Evans A, Manson A, et al. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004;75(12):1672-1677.
- Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42(3):267-278.
- Raguthu L, Varanese S, Flancbaum L, Tayler E, Di Rocco A. Fava beans and Parkinson's disease: useful 'natural supplement' or useless risk?. Eur J Neurol. 2009;16(10):e171.
- Multari S, Stewart D, Russell W. Potential of fava bean as future protein supply to partially replace meat intake in the human diet. Comp Rev Food Sci F. 2015;14:511-522.
- Cardador-Martinez A, et al. Effect of roasting and boiling on the content of vicine, convicine and l-3,4-dihydroxyphenylalanine in vicia faba l. J Food Quality. 2012;35(6):419-428.
- Goyoaga C. et al. Content and distribution of vicine, convicine and L-DOPA during germination and seeding growth of two Vicia faba L. varieties. Eur Food Res Technol. 2008;227:1537-1542.
- Vered Y, et al. Bioavailability of lveodopa after consumption of Vicia faba seedlings by Parkinsonian patients and controll subjects. Clin Neuropharmacol. 1994;17(2):138-146.
- Nagashima Y, Kondo T, Sakata M, Koh J, Ito H. Effects of soybean ingestion on pharmacokinetics of levodopa and motor symptoms of Parkinson's disease—In relation to the effects of Mucuna pruriens. J Neurol Sci. 2016;361:229-234.
Motion graphics by Avo Media
Below is an approximation of this video’s audio content. To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video.
Intro: Treating Parkinson’s disease with velvet beans. I have several videos on foods that may trigger Parkinson’s disease, but how can diet be used in treatment? This video and the next look at beans for treating this disease.
Two centuries have passed since James Parkinson’s Essay on the Shaking Palsy described a disease characterized by tremor and problems with movement. Today, treatment options include surgically implanting electrodes into the brain. There has to be a better way.
We’ve known since the 1950s that Parkinson’s disease is manifested by a dopamine deficiency in the brain. Well, then why not eat a dopamine diet? A variety of fruits and vegetables contain the same dopamine made by our brain. Unfortunately, dopamine can’t cross the blood-brain barrier, and hence is ineffective as therapy. However, the dopamine precursor, known as L-dopa or levodopa, can get from the blood up into the brain, where it can then be converted to dopamine within the brain by an enzyme called decarboxylase. We don’t want the levodopa to be converted to dopamine outside the brain, because then it can’t get in. So, we give people a decarboxylase inhibitor, which itself can’t get into the brain; so, that keeps levodopa from prematurely turning into dopamine before it gets into the brain where we need it.
So, eating dopamine-rich foods doesn’t help, but what if we ate levodopa-rich foods? More than 1,500 years before Dr. Parkinson came on the scene, an Indian physician seems to have nailed it, and even suggested a treatment—velvet beans, the plant with the highest amount of L-dopa. Hmm; so, might there be a way to forestall the epidemic of Parkinson’s disease through plant-based remedies after all?
Levodopa is the gold standard therapy for Parkinson’s patients, but most Parkinson’s patients in low-income areas cannot afford long-term daily levodopa therapy. In rural Africa, for example, it is estimated that only 15 percent of patients are treated with levodopa, because the daily cost of levodopa treatment is about a dollar a day, which may be half of what people make in a day. It’s the same with other regions of the Global South. L-dopa is mostly unavailable or unaffordable. So, patients frequently use powdered velvet beans as a replacement or supplement to the drug.
But does it work? You never know, until you put it to the test. Velvet beans in Parkinson’s disease: a randomized, double blind clinical study. And…a dose of 30g (which is about three tablespoons) led to reliable and sustained antiparkinsonian effects in all patients, working significantly quicker than the drug; working significantly longer than the drug; and working significantly better than the drug in another double-blind, randomized, head-to-head crossover study.
The levodopa in velvet beans appears to be two to three times more potent as compared to the same dose of pill-form levodopa––suspected to be because there may be some intrinsic decarboxylase inhibitor compound in the plant as well.
Okay, but those were single dose studies. What about the chronic use of velvet beans for Parkinson’s? Fourteen patients with advanced Parkinson’s received roasted velvet bean powder or the standard drug, switching back and forth for months, looking at changes in quality of life, activities of daily living, movement and non-movement symptoms, and time with good mobility without troublesome involuntary writhing movements. The velvet beans seemed to work as well as the drug in all measures of efficacy, including quality of life. Here’s a video you can see someone with Parkinson’s solely treated with velvet bean powder for 14 years, before and after treatment.
Despite the efficacy, the chances of this cheap herbal remedy ever being licensed seems unlikely—and for good reason. First of all, the stuff evidently tastes nasty. And we don’t really have good data going out more than a few months. While velvet beans may potentially be part of the answer to Parkinson’s disease management in low-income countries, in high-income countries, one may be tempted to prefer them to drugs just because it is a “more natural therapy,” but researchers discourage patients and physicians to consider its use when the drugs are available. So, levodopa in pill form should remain the first-line treatment for Parkinson’s. However, velvet bean powder may be better tolerated in certain patients. Psychologically, some patients just have a thing against taking pills and so, if they refuse, then certainly the beans can step in. But otherwise, velvet bean supplements suffer from the same issues common to all supplements, specifically lack of sufficient regulation and quality control. There are all sorts of brands out there, but there are no head-to-head comparisons as to which is best, and the quality of the products likely vary. But you don’t know, until you put it to the test.
Six brands of velvet bean products were ordered through the internet and most of them, four out of six, showed a large discrepancy between the claim on their label and the actual L-Dopa content, and only two even came close. The remaining products contained considerably less—less than 10 percent in two cases. Too bad there isn’t a food source of L-dopa that you could just eat instead of taking in a supplement. Well, wait a second. L-dopa was originally discovered more than a century ago in faba beans. Might eating faba beans help with Parkinson’s? I’ll explore just that question next.
“Increased risk of Parkinson’s disease has been associated with exposure to pesticides, consumption of dairy products, a history of melanoma, and traumatic brain injury.” Why is the risk of Parkinson’s disease increased among individuals with high milk and dairy consumption? It could be the animal fat, or maybe the animal protein. So, why not use a plant-food diet for the risk and management of Parkinson’s disease? There are phytochemicals that may target the underlying cause, but in terms of treatment, ancient sacred texts from thousands of years ago refer to “trembling” individuals who were prescribed a plant from the bean family to treat the condition.
In my last video, Treating Parkinson’s Disease with Velvet Beans, I talked about the use of velvet beans. But in 1913, the miracle drug L-dopa was discovered for the first time in faba beans, also known as fava beans or broad beans, as a natural source of L-dopa to consider. The amount varies considerably based on a number of factors, but typically it looks like they have about 10 times less than velvet beans. But that’s okay since you can eat larger quantities, since fava beans are an actual food instead of a powdered supplement. The important thing is that the amount of L-dopa in fava beans is enough to be pharmacologically active in Parkinson’s disease. In fact, there are some reports indicating that Parkinson’s patients might respond better to the beans than to standard L-dopa preparations in pill form. But anecdotal reports that patients may gain benefit from a broad bean-rich diet don’t cut it. What you have to do is put it to the test.
Parkinson’s patients were fed about one and a third cups of cooked fava beans, and during the next four hours, a substantial clinical improvement was noted. In fact, it was similar to the improvement seen after receiving the standard pharmacological combination of L-dopa plus carbidopa, the decarboxylase inhibitor drug I talked about in the last video that boosts L-dopa levels in the brain. It’s no surprise that there was a similar effect, since they had very similar L-dopa levels in the blood. In fact, half the time you could hardly tell the beans from the drugs. How could there be the same levels if the bean L-dopa lacked the carbidopa booster drug? Because fava beans may not only be a natural source of L-dopa, but a natural source of the carbidopa booster too. So, the consumption of fava beans has the potential to increase the levels of L-dopa and carbidopa in the blood, with a marked improvement in the muscle movement performance of the patients with Parkinson disease, without any side effects.
In fact, they work so well you have to be careful about abruptly stopping them. There’s a condition called neuroleptic malignant-like syndrome, characterized by fever, rigidity, all sorts of neurological problems, muscle breakdown, and altered levels of consciousness, which is usually precipitated by an abrupt withdrawal of the L-dopa drug, caused by an acute dopamine-deficient state. Well, you can see the same thing if you’re treating your Parkinson’s with fava beans, and then all the sudden you stop them. Ten days before hospital admission, this poor guy’s garden ran out of beans, leading to a severe crippling rigidity. This case demonstrates that alternative therapies carry similar risks to traditional agents, because in this case they really are the ultimate traditional agent.
There are some downsides you don’t see with the drug, though. Like fava-induced flatulence. You also have to be careful with fava consumption if you’re on MAO inhibitor drugs, often used as anti-depressants, since there can be drug interactions.
And then there is the risk of a condition known as favism. There is a genetic mutation that occurs in about 1 in 20 people, and at even higher rates in those of African and Mediterranean descent, in which people lack an enzyme that’s necessary to detoxify certain compounds found in fava beans. And without the enzyme, fava bean consumption can cause your red blood cells to rupture. Thankfully, genetic testing for this mutation is widely available and affordable, and so it would seem prudent to screen patients with Parkinson’s for this favism, called G6PD deficiency mutation, prior to putting them on daily fava bean consumption.
If you do want to give fava beans a try, fresh green fava beans have significantly more L-dopa than dried. So much so that dried fava beans may not provide any clinical benefits.
Roasting and boiling removes some or even all of the L-dopa, though other studies have found that about a half cup of cooked favas contain approximately 250 mg. Sprouted favas may have the most, increasing up until day nine, by which time the indigestible flatulence sugars may be eliminated, offering another advantage of fava bean sprouting. But you don’t know if fava bean sprouts help until you put them to the test.
Researchers fed Parkinson’s patients a salad with about a half cup of freshly chopped fava sprouts and observed substantial clinical improvement.
Other beans, just like regular beans, also naturally have L-dopa, though at lower amounts. Soybeans have a bonus compound that may act as an L-dopa-boosting carbidopa compound. What if you fed people soybeans on top of their regular Parkinson’s meds? Giving people just one and a half spoonful’s worth of roasted soybeans led to a significant improvement over the drugs alone, with significantly fewer involuntary movements hours later.
Until more information is available, Parkinson’s combo drugs like Sinemet should remain the first-line therapy, but adding beans to one’s diet may only help.
Please consider volunteering to help out on the site.
- Del Rey NL, Quiroga-Varela A, Garbayo E, et al. Advances in Parkinson's Disease: 200 Years Later. Front Neuroanat. 2018;12:113.
- Hornykiewicz O. The discovery of dopamine deficiency in the parkinsonian brain. J Neural Transm Suppl. 2006;(70):9-15.
- Briguglio M, Dell'Osso B, Panzica G, et al. Dietary Neurotransmitters: A Narrative Review on Current Knowledge. Nutrients. 2018;10(5):591.
- Ahlskog JE. Parkinson’s disease: medical and surgical treatment. Neurol Clin. 2001;19(3):579-605, vi.
- Rijntjes M. Knowing Your Beans in Parkinson's Disease: A Critical Assessment of Current Knowledge about Different Beans and Their Compounds in the Treatment of Parkinson's Disease and in Animal Models. Parkinsons Dis. 2019;2019:1349509.
- Banjari I, Marček T, Tomić S, Waisundara VY. Forestalling the Epidemics of Parkinson's Disease Through Plant-Based Remedies. Front Nutr. 2018;5:95.
- Cassani E, Cilia R, Laguna J, et al. Mucuna pruriens for Parkinson's disease: Low-cost preparation method, laboratory measures and pharmacokinetics profile. J Neurol Sci. 2016;365:175-180.
- Cilia R, Laguna J, Cassani E, et al. Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study. Neurology. 2017;89(5):432-438.
- Merello M. The Dark Side of Globalization: Lack of Universal Levodopa Availability. Mov Disord Clin Pract. 2018;6(1):7-8.
- Katzenschlager R, Evans A, Manson A, et al. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004;75(12):1672-1677.
- Rai SN, Birla H, Zahra W, Singh SS, Singh SP. Immunomodulation of Parkinson's disease using Mucuna pruriens (Mp). J Chem Neuroanat. 2017;85:27-35.
- Cilia R, Laguna J, Cassani E, et al. Chronic Mucuna pruriens in Parkinson’s disease: a non-inferiority, randomised, crossover, phase-2b trial. Parkinsonism Relat Disord. 2018;46:e24.
- Lees AJ. Advice for those trying to find a cure for the shaking palsy. Lancet Neurol. 2018;17(1):27-28.
- Cilia R, Laguna J, Cassani E, et al. Daily intake of Mucuna pruriens in advanced Parkinson's disease: A 16-week, noninferiority, randomized, crossover, pilot study. Parkinsonism Relat Disord. 2018;49:60-66.
- Fothergill-Misbah N, Maroo H, Cham M, Pezzoli G, Walker R, Cilia R. Could Mucuna pruriens be the answer to Parkinson's disease management in sub-Saharan Africa and other low-income countries worldwide?. Parkinsonism Relat Disord. 2020;73:3-7.
- Margolesky J, Shpiner DS, Moore H, Singer C, Jagid J, Luca CC. From Mucuna Pruriens to deep brain stimulation: A two-decade case history. Parkinsonism Relat Disord. 2020;77:26-27.
- Denne T. Analysis of Levodopa Content in Commercial Formulations of Mucuna pruriens Seeds Used in Integrative Treatment of Parkinson’s Disease [abstract]. Mov Disord. 2019; 34 (suppl 2).
- Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257-1272.
- Baroni L, Zuliani C. A plant-food diet in the risk and management of parkinson’s disease. In: Bioactive Nutraceuticals and Dietary Supplements in Neurological and Brain Disease. Elsevier; 2015:411-420.
- Javed H, Nagoor Meeran MF, Azimullah S, Adem A, Sadek B, Ojha SK. Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models. Front Pharmacol. 2019;9:1555.
- Ramírez-Moreno JM, Salguero Bodes I, Romaskevych O, Duran-Herrera MC. Broad bean (Vicia faba) consumption and Parkinson's disease: a natural source of L-dopa to consider. Neurologia. 2015;30(6):375-376.
- Cilia R, Laguna J, Cassani E, et al. Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study. Neurology. 2017;89(5):432-438.
- Guggenheim M. Dioxyphenylalanin, eine neue Aminosäure aus Vicia faba. Z Phys Chem. 1913;88:276.
- Rijntjes M. Knowing Your Beans in Parkinson's Disease: A Critical Assessment of Current Knowledge about Different Beans and Their Compounds in the Treatment of Parkinson's Disease and in Animal Models. Parkinsons Dis. 2019;2019:1349509.
- Sarrafchi A, Bahmani M, Shirzad H, Rafieian-Kopaei M. Oxidative stress and Parkinson's disease: New hopes in treatment with herbal antioxidants. Curr Pharm Des. 2016;22(2):238-246.
- Kempster PA, Bogetic Z, Secombei JW, Martin HD, Balazs ND, Wahlqvist ML. Motor effects of broad beans (Vicia faba) in Parkinson's disease: single dose studies. Asia Pac J Clin Nutr. 1993;2(2):85-89.
- Rabey JM, Vered Y, Shabtai H, Graff E, Korczyn AD. Improvement of parkinsonian features correlate with high plasma levodopa values after broad bean (Vicia faba) consumption. J Neurol Neurosurg Psychiatry. 1992;55(8):725-727.
- Mehran S M M, B G. Simultaneous determination of levodopa and carbidopa from fava bean, green peas and green beans by high performance liquid gas chromatography. J Clin Diagn Res. 2013;7(6):1004-1007.
- Ladha SS, Walker R, Shill HA. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance. Mov Disord. 2005;20(5):630-631.
- Katzenschlager R, Evans A, Manson A, et al. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. J Neurol Neurosurg Psychiatry. 2004;75(12):1672-1677.
- Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis. 2009;42(3):267-278.
- Raguthu L, Varanese S, Flancbaum L, Tayler E, Di Rocco A. Fava beans and Parkinson's disease: useful 'natural supplement' or useless risk?. Eur J Neurol. 2009;16(10):e171.
- Multari S, Stewart D, Russell W. Potential of fava bean as future protein supply to partially replace meat intake in the human diet. Comp Rev Food Sci F. 2015;14:511-522.
- Cardador-Martinez A, et al. Effect of roasting and boiling on the content of vicine, convicine and l-3,4-dihydroxyphenylalanine in vicia faba l. J Food Quality. 2012;35(6):419-428.
- Goyoaga C. et al. Content and distribution of vicine, convicine and L-DOPA during germination and seeding growth of two Vicia faba L. varieties. Eur Food Res Technol. 2008;227:1537-1542.
- Vered Y, et al. Bioavailability of lveodopa after consumption of Vicia faba seedlings by Parkinsonian patients and controll subjects. Clin Neuropharmacol. 1994;17(2):138-146.
- Nagashima Y, Kondo T, Sakata M, Koh J, Ito H. Effects of soybean ingestion on pharmacokinetics of levodopa and motor symptoms of Parkinson's disease—In relation to the effects of Mucuna pruriens. J Neurol Sci. 2016;361:229-234.
Motion graphics by Avo Media
Republishing "Friday Favorites: Can Velvet Beans or Fava Beans Help Treat Parkinson’s Disease?"
You may republish this material online or in print under our Creative Commons licence. You must attribute the article to NutritionFacts.org with a link back to our website in your republication.
If any changes are made to the original text or video, you must indicate, reasonably, what has changed about the article or video.
You may not use our material for commercial purposes.
You may not apply legal terms or technological measures that restrict others from doing anything permitted here.
If you have any questions, please Contact Us
Friday Favorites: Can Velvet Beans or Fava Beans Help Treat Parkinson’s Disease?
LicenseCreative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Content URLDoctor's Note
I have many more videos on Parkinson’s disease, such as:
- Preventing Parkinson’s Disease with Diet
- Treating Parkinson’s Disease with Diet
- The Role Meat May Play in Triggering Parkinson’s Disease
- Coffee Put to the Test for Treating Parkinson’s Disease
- Low Protein Diets for Parkinson’s Disease
- Peppers and Parkinson’s: The Benefits of Smoking Without the Risks?
- Could Lactose Explain the Milk and Parkinson’s Disease Link?
- Parkinson’s Disease and the Uric Acid Sweet Spot
The original video aired on February 6 and 8, 2023
If you haven't yet, you can subscribe to our free newsletter. With your subscription, you'll also get notifications for just-released blogs and videos. Check out our information page about our translated resources.